Barclays’s Global X Funds Global X HealthTech ETF HEAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$41K Hold
1,721
﹤0.01% 4388
2025
Q4
$50.3K Hold
1,721
﹤0.01% 4742
2025
Q3
$55K Hold
1,721
﹤0.01% 4749
2025
Q2
$56.3K Hold
1,721
﹤0.01% 4693
2025
Q1
$48.8K Hold
1,721
﹤0.01% 4616
2024
Q4
$50.8K Hold
1,721
﹤0.01% 4758
2024
Q3
$51.7K Hold
1,721
﹤0.01% 4738
2024
Q2
$45.2K Hold
1,721
﹤0.01% 4244
2024
Q1
$49.1K Buy
1,721
+690
+67% +$19.7K ﹤0.01% 4617
2023
Q4
$31.3K Hold
1,031
﹤0.01% 4839
2023
Q3
$28.4K Hold
1,031
﹤0.01% 4077
2023
Q2
$36K Buy
+1,031
New +$35.8K ﹤0.01% 3972

Other funds holding HEAL

Barclays's HEAL Position: Q1 2026 in Review

Barclays held its Global X Funds Global X HealthTech ETF (HEAL) position steady in Q1 2026 at 1,721 shares worth $41K. The position accounts for ﹤0.01% of the portfolio, ranked #4388.

Barclays first reported a position in HEAL in Q2 2023 and has held it in 12 quarters since. The position peaked at $56.3K in Q2 2025. 30 funds tracked by Wall St. Rank hold HEAL as of Q1 2026.

  • Barclays held 1,721 shares of Global X Funds Global X HealthTech ETF worth $41K as of Q1 2026.
  • Barclays left its Global X Funds Global X HealthTech ETF share count unchanged in Q1 2026.
  • Global X Funds Global X HealthTech ETF made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #4388 holding.
  • Barclays first reported a position in Global X Funds Global X HealthTech ETF in Q2 2023 and has held it in 12 quarters since.
  • Barclays's Global X Funds Global X HealthTech ETF position peaked at $56.3K in Q2 2025.
  • 30 funds tracked by Wall St. Rank held Global X Funds Global X HealthTech ETF as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.